Chronic high glucose induces apoptosis and proteasome activities decrease in INS-1E cells. by Christophe Broca (538652)

The G215S mutation decreases packaging of N and growth in primary differentiated human bronchial cells. by Hannah C. Kubinski (21213168)

Decreasing Fertility Rate Correlates with the Chronological Increase and Geographical Variation in Incidence of Kawasaki Disease in Japan by Yoshiro Nagao (50850)

<i>Pw1</i> deletion does not result in significant decrease in oxytocin production and release. by Anne-Lyse Denizot (3170142)

Decrease in the hemolymph sugar level of hyperglycemic silkworms and increase in AMPK phosphorylation in the fat body by AICAR. by Yasuhiko Matsumoto (206628)

TGF-β₁ increases proliferation but decreases AP activity in cultured osteoblasts. by Sabrina Ehnert (359631)

“…<p>Primary human osteoblasts were treated for 8 days with different conc. (0, 1, 2.5, 5, 10 ng/ml) of hra TGF-β₁. (A) SRB staining of surface proteins showed that TGF-β₁ dose-dependently increased proliferation of osteoblasts. …”

U0126 decreases the LPS-induced increased accessibility of the G-CSF promoter to DNase I. by Shwu-Fen Chang (761846)

Decreased survival, splenomegaly, thrombocytopenia and megakaryocyte alterations in SCID-Rasa3^−/− mice. by Patricia Molina-Ortiz (167505)

Definitions of the features selected [50]. by Yu Zhang (12946)

Discrimination of rippled-spectrum patterns in noise: A manifestation of compressive nonlinearity - Fig 6 by Olga N. Milekhina (812701)

c-Yes knock-down increases apoptosis and decreases growth in soft-agar and in mouse xenografts. by Florence Sancier (229473)

<i>Pf-Rel</i> knockdown decreased the <i>Nacrein</i> gene expression level. by Juan Sun (439334)

“…Both <i>Nacrein</i> and <i>Pf-Rel</i> mRNA expression level in controls are attributed a relative value of 1.0. tm-3-15 and tm-6-15: samples injected with15 ng <i>Pif-Rel</i> dsRNA 3 or 6 days respectively. …”

AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial by Soraya Allas (4752756)

“…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. …”

Decreased motor coordination deficits in <i>Cln6^nclf</i> mice. by Jeremy P. Morgan (479017)

SHIP-1 decreases NOD2-induced NF-κB activation in epithelial cells. by Claude Condé (150801)

Random forest analysis showing discriminating biomarkers of diet-challenge in their decreasing orders of mean decrease accuracies (MDA). by Biswapriya B. Misra (563793)

Silencing of Doublecortin-Like (DCL) Results in Decreased Mitochondrial Activity and Delayed Neuroblastoma Tumor Growth by Carla S. Verissimo (463419)

FG-2216 decreased plasma markers of cardiac injury in Nx-Ob-ZSF1 rats. by Pierre E. Signore (11218497)

The mutation D2267N within the G3 domain decreases the complement activation capacity. by Camilla Melin Fürst (402462)

B-RAF inhibitor PLX4720 decreased hERG currents in rhabdomyosarcoma RD cells. by Tatsiana Pakladok (311653)